| Document |
Document Title |
|
WO/2020/081612A1 |
This disclosure describes various reaction vessel configurations that include a housing component; a reaction chamber defined by the housing component; and a light absorbing layer conforming to a portion of an interior-facing surface of ...
|
|
WO/2020/075046A1 |
The application relates to N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxa
zole-5- carboxamide (Compound I) fumaric acid co-crystals and X- ray amorphous complexes of Compound (I) and...
|
|
WO/2020/076793A1 |
This disclosure provides for routes of synthesis of acrylic acid and other a,b-unsaturated carboxylic acids and their salts, including catalytic methods. For example, there is provided a process for producing an α,β-unsaturated carboxy...
|
|
WO/2020/075762A1 |
In a method which separates solid and liquid from a slurry that comprises (meth)acrylic acid crude crystal and a mother liquor in a chamber, a crude crystal in which the amount of the mother liquor, specifically methanol as a solvent has...
|
|
WO/2020/071935A1 |
The present invention relates to choline salts of fumaric acid for use as ingredients in dietary supplements, in medical nutrition, and in pharmaceutical compositions for the prevention and treatment of diseases caused by hypoxia.
|
|
WO/2020/059704A1 |
Provided is a Mo-V-based oxide catalyst for producing methacrylic acid at a higher yield than conventional catalysts. This catalyst for producing methacrylic acid is used in producing methacrylic acid by methacrolein oxidation, said cata...
|
|
WO/2020/050368A1 |
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...
|
|
WO/2020/048516A1 |
The present invention relates to the technical field of extraction and separation of natural plant active ingredients, in particular to a method for separating trans isomeric crocetin from cis isomeric crocetin. Crocetin is a carotenoid ...
|
|
WO/2020/037164A1 |
Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.
|
|
WO/2020/030374A1 |
The present invention relates to a process for producing methacrylic acid or methacrylic acid esters. The present invention is directed to a new process for the production of methacrylic acid or alkyl methacrylate starting from Acrolein,...
|
|
WO/2020/028426A1 |
The subject invention relates to novel methods for the rapid treatment of disorders resulting from thrombosis or embolism such as a myocardial infarction or stroke. Specifically, the invention relates to diffusion enhancing compounds and...
|
|
WO/2020/020697A1 |
The invention relates to a method for inhibiting unwanted radical polymerisation of acrylic acid present in a liquid phase P, wherein: the acrylic acid content of P is at least 10% by weight; the liquid phase P contains 25 to 1,000 ppm b...
|
|
WO/2020/020873A1 |
The invention relates to a process for preparing a compound of (III) wherein X is a leaving group; and R1 is C1-C6 alkyl; which comprises oxidative rearrangement of a compound of formula (II) or a solvate thereof Compounds of formula (II...
|
|
WO/2020/014776A1 |
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...
|
|
WO/2020/014596A1 |
Described are compositions and methods for inhibiting polymerization of a monomer (e.g., styrene) composition, which use an N-O polymerization inhibitor, a quinone methide polymerization retarder, and an amine stabilizer having a primary...
|
|
WO/2020/011020A1 |
A mefatinib composition, related compounds, a preparation method therefor and use thereof. The mefatinib composition comprises mefatinib represented by formula (I) and a compound represented by formula (II) having a normalized percentage...
|
|
WO/2020/013064A1 |
A catalyst that contains molybdenum (Mo) as an essential element and includes other catalytically active ingredients, in which the constituent elements satisfy relationship (cI). (cI): 0.44≤Σ{(MoIE−XIE)×XC}≤1.53 [In relationship ...
|
|
WO/2020/004172A1 |
Provided are organically modified metal oxide nanoparticles that can be produced in a simple manner and that can increase the sensitivity and resolution of resist materials. A EUV photoresist material includes organically modified metal ...
|
|
WO/2020/006557A1 |
The present invention is directed to itaconic acid derivatives, compounds comprising the derivatives and methods of using the derivatives in the treatment of cancer, inflammation, and autoimmune diseases.
|
|
WO/2019/245048A1 |
The problem to be addressed by the present invention is to provide a novel production method for an α-fluoroacrylic acid ester compound. The problem is addressed by the production method for the compound represented by formula (1) [in t...
|
|
WO/2019/240058A1 |
Provided are: a fullerene compound; a lubricant that is for a magnetic recording medium and that contains the fullerene compound; and a magnetic recording medium. The fullerene compound according to the present invention is characterized...
|
|
WO/2019/217536A9 |
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...
|
|
WO/2019/224141A1 |
A fumarate salt, in particular the hemi-fumarate salt, of 5-((5-methyl-2-((3,4,5-trimethylphenyl)amino)pyrimidin-4-yl)
amino)-benzo[d]oxazol-2(3H)-one (Compound (I), compositions comprising such a salt, and processes for the manufacture ...
|
|
WO/2019/219093A2 |
A preparation of zinc linoleate, and an application thereof in preparing an anti-helicobacter pylori drug. Zinc chloride is dissolved in sterile water, and the zinc chloride solution is heated and activated in a reactor, then naturally c...
|
|
WO/2019/213026A1 |
The present disclosure relates to an electrophotographic printing method comprising electrophotographically printing a liquid electrophotographic composition onto a substrate. The liquid electrophotographic composition comprises a charge...
|
|
WO/2019/208807A1 |
The present invention provides a method for manufacturing a high-purity aromatic nitrile compound and aromatic carboxylic acid compound safely, inexpensively, and with high efficiency. A compound (2) is subjected to the Willgerodt reacti...
|
|
WO/2019/207264A1 |
The invention relates to a process for recycling (100) an item based on thermoplastic (meth)acrylic polymer resin, characterized in that it comprises the following steps: - introduction (110) of the item into a system suitable for thermo...
|
|
WO/2019/208715A1 |
Provided is a catalyst for methacrylic-acid production which heightens the yield of methacrylic acid and is usable as an industrial catalyst. The present invention relates to a method for producing the catalyst, which at least includes p...
|
|
WO/2019/198763A1 |
A method for producing at least one of an unsaturated aldehyde and an unsaturated carboxylic acid, in which a n-layered catalyst layer (n ≥ 2) is provided as observed in the direction of the flow of a gas in a reaction tube, two or mor...
|
|
WO/2019/199753A1 |
The invention relates to novel linear, semi-crystalline, functional fluoropolymers that have been obtained by copolymerizing a fluorinated vinylic monomer and a hydrophilic monomer chosen from vinyl alkyl acids, vinyl phosphonates, funct...
|
|
WO/2019/195942A1 |
A method for increasing gastric tract acid (GTA) production in a mammalian subject. The method comprises administering a therapeutically-effective amount of a composition comprising at least one live or attenuated culture of a microbial ...
|
|
WO/2019/197232A1 |
The invention relates to a multi-stage process for producing 2,6-dialkylphenyl acetic acids of general formula (I) by reacting 2,6-dialkyl bromobenzenes with (1) magnesium, (2) a formamide, (3) an acid, (4) hydrogenation of the benzaldeh...
|
|
WO/2019/199752A1 |
The invention relates to novel linear, semi-crystalline, functional fluoropolymers that have been obtained by copolymerizing a fluorinated vinylic monomer and a hydrophilic (meth)acrylic comonomer bearing a halogen functionality.
|
|
WO/2019/190823A1 |
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-p
henoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzh...
|
|
WO/2019/188507A1 |
Provided is a method for producing an α，β-unsaturated carboxylate, the method comprising: a step (1) for reacting a transition metal complex, alkene and carbon dioxide to obtain a metal lactone compound expressed by formula (1) [in t...
|
|
WO/2019/188955A1 |
This catalyst for manufacturing unsaturated carboxylic acid includes an active component expressed by formula (A), wherein a ratio of a diffraction line intensity at 2θ=19.1±0.3°to a diffraction line intensity at 2θ=10.7±0.3° in an...
|
|
WO/2019/182089A1 |
A catalyst for producing an unsaturated aldehyde and an unsaturated carboxylic acid, wherein: the integrated pore volume (A) of pores in the catalyst, said pores having a pore diameter of 1-100 μm inclusive, is 0.12-0.19 ml/g inclusive;...
|
|
WO/2019/182713A1 |
Provided is a process for preparing acrylic acid comprising (1) preparing acrolein by catalytic gas phase oxidation comprising (a) providing a reaction gas comprising (i) 5 to 10 mol % propylene, (ii) 0.02 to 0.75 mol % propane, and (iii...
|
|
WO/2019/174063A1 |
Disclosed is a chemical reaction apparatus, the apparatus comprising: a reaction unit, a separation unit, and a recovery unit; the reaction unit, the separation unit, and the recovery unit are connected in sequence; and the reaction unit...
|
|
WO/2019/177031A1 |
The present invention provides a catalyst molded body which has high yield and high mechanical strength. This catalyst molded body contains: a catalyst for the production of an unsaturated aldehyde and an unsaturated carboxylic acid, or ...
|
|
WO/2019/174064A1 |
Provided is a bubbling bed synthesis reactor, said reactor comprising a catalytic reaction section and a catalyst settling section, the cross-sectional area of at least one position of the catalytic reaction section being smaller than th...
|
|
WO/2019/163984A1 |
Provided is a catalyst for producing an α,β-unsaturated carboxylic acid at a high yield. The present invention also provides a method for preparing a catalyst for producing an α,β-unsaturated carboxylic acid, the catalyst being used ...
|
|
WO/2019/163707A1 |
Provided are: a catalyst by which the amount of a high-boiling aromatic compound formed as a by-product is reduced so that stable operation can be performed over a long time and a final product can be acquired at a high yield; and a dire...
|
|
WO/2019/158611A1 |
The present invention relates to a method for isomerizing a 3-(Z)-unsaturated carboxylic acid of the formula l-Z or a salt thereof, wherein R2 is C1-C24-alkyl, C2-C24-alkenylhaving 1, 2, 3 or more than 3 C-C double bonds, unsubstituted o...
|
|
WO/2019/158285A1 |
Object of the present invention is an efficient process for the preparation of the active pharmaceutical ingredient Sitagliptine and the 2,4,5-trifluorophenylacetic acid (TFAA) and salt thereof, which is a key intermediate for the synthe...
|
|
WO/2019/155128A1 |
According to an example aspect of the present invention, there is provided a method for producing muconic acid ester from aldaric acid ester, and for separating and purifying the produced muconic acid ester by high vacuum distillation in...
|
|
WO/2019/142862A1 |
The present invention relates to a method of producing (meth)acrylic acid or ester thereof which includes a step of generating distillation gas from process fluid that comprises (meth)acrylic acid or ester thereof under reduced pressure ...
|
|
WO/2019/142887A1 |
Provided is a method for suppressing polymerization of vinyl monomers, which has improved polymerization suppression effect for vinyl monomers. The present invention provides a method for suppressing polymerization of vinyl monomers, whi...
|
|
WO/2019/134984A1 |
A compound of the formula (I)wherein R represents a straight or branched, primary or secondary acyclic hydrocarbyl C3–C15 group, which can be saturated or unsaturated, or a straight or branched, primary or secondary acyclic hydrocarbyl...
|
|
WO/2019/127747A1 |
Disclosed are a phenyl acrylic acid esther compound, and a pharmaceutically acceptable salt, solvate and prodrug thereof, a tautomer or a stereochemical isomer or a pharmaceutical composition, and uses of the pharmaceutical composition a...
|
